Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · Real-Time Price · USD
2.170
+0.030 (1.40%)
At close: Apr 13, 2026, 4:00 PM EDT
2.220
+0.050 (2.30%)
After-hours: Apr 13, 2026, 7:57 PM EDT

CELZ Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
8746514
Market Cap Growth
105.69%79.39%-36.22%18.07%-61.72%-34.43%
Enterprise Value
0.837.274.05-3.64-13.023.3
Last Close Price
2.171.962.314.613.8122.10
PE Ratio
--0.78-0.62-1.23-0.410.39
PS Ratio
1336.961207.58367.17703.6060.53159.64
PB Ratio
1.070.480.320.610.341.37
P/TBV Ratio
0.350.310.270.630.260.70
P/FCF Ratio
--1.24-0.76-0.79-0.69-6.32
P/OCF Ratio
--1.24-0.76-0.79-0.69-6.32
EV/Sales Ratio
137.971211.61368.46-404.49-146.9737.60
EV/EBITDA Ratio
--1.21-0.720.661.28-1.09
EV/EBIT Ratio
--1.18-0.710.651.27-1.06
EV/FCF Ratio
--1.24-0.760.451.67-1.49
Debt / Equity Ratio
0.000.000.000.000.000.00
Debt / EBITDA Ratio
0.000.000.000.000.000.00
Debt / FCF Ratio
0.000.000.000.000.00-0.01
Net Debt / Equity Ratio
0.000.000.00-0.96-1.16-1.05
Net Debt / EBITDA Ratio
0.000.000.001.811.813.53
Net Debt / FCF Ratio
0.000.000.001.242.364.83
Asset Turnover
0.010.010.000.000.010.01
Inventory Turnover
2.002.001.000.432.718.83
Quick Ratio
0.180.18026.895.5410.21
Current Ratio
0.670.670.5927.665.6410.22
Return on Equity (ROE)
-43.23%-43.23%-47.71%-40.34%-77.78%-129.87%
Return on Assets (ROA)
-923.63%-923.63%-100.38%-37.59%-67.28%-52.16%
Return on Invested Capital (ROIC)
-1646.86%-1646.86%-1461.13%522.96%680.19%734.11%
Return on Capital Employed (ROCE)
-1712.01%-1712.01%-106.91%-42.89%-78.55%21.13%
Earnings Yield
-74.73%-128.57%-160.61%-81.56%-243.57%253.85%
FCF Yield
--80.83%-131.26%-126.77%-145.38%-15.82%
Buyback Yield / Dilution
-60.95%-60.95%-5.17%-28.76%-236.51%-460.63%
Total Shareholder Return
-60.95%-60.95%-5.17%-28.76%-236.51%-460.63%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q